Literature DB >> 17993773

Familial pituitary adenomas with a heterogeneous functional pattern: clinical and genetic features.

G Raverot1, W Arnous, A Calender, J Trouillas, G Sassolas, C Bournaud, M Pugeat, F Borson-Chazot.   

Abstract

Familial pituitary adenoma is a rare syndrome which may present either as isolated lesions, or in association with other endocrine tumors, for example in the frame of multiple endocrine neoplasia (MEN-1) or Carney complex (CNC). The most frequently described forms of familial isolated pituitary adenoma (FIPA) are familial somatotropinomas or prolactinomas. Recently, some cases of familial isolated somatotropinoma have been associated with germline mutations in the aryl hydrocarbon receptor interacting protein (AIP) gene. The present report shows heterogeneous FIPA with 3 subtypes of tumor in 3 individuals of the same family: somatotropinoma in the proband, giant prolactinoma in a brother, and gonadotroph cell macroadenoma in the father. A prospective survey also suggested the occurrence of a silent microadenoma in the proband's sister. Clinical screening was performed in the 3 affected members, the 4th suspected case, and 9 additional, asymptomatic relatives. They had no clinical evidence of associated endocrine lesion suggesting MEN-1 or CNC. Genetic screening for germline mutation of the MEN-1, the gene encoding the protein kinase A (PKA) type 1 alpha regulatory subunit (R1 alpha) (PRKAR1alpha) and AIP gene was negative in 2 affected members. In conclusion, these data suggest that familial pituitary adenomas can occur with a heterogeneous functional pattern that is distinguished from MEN-1 or CNC. The absence of mutation of the recently described AIP gene suggests the implication of other predisposing gene(s). Collaborative, multicentric studies are needed to further define the location of gene(s) involved in heterogeneous FIPA.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17993773     DOI: 10.1007/BF03350819

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  14 in total

1.  Clinical characterization of familial isolated pituitary adenomas.

Authors:  A F Daly; M-L Jaffrain-Rea; A Ciccarelli; H Valdes-Socin; V Rohmer; G Tamburrano; C Borson-Chazot; B Estour; E Ciccarelli; T Brue; P Ferolla; P Emy; A Colao; E De Menis; P Lecomte; F Penfornis; B Delemer; J Bertherat; J L Wémeau; W De Herder; F Archambeaud; A Stevenaert; A Calender; A Murat; F Cavagnini; A Beckers
Journal:  J Clin Endocrinol Metab       Date:  2006-06-20       Impact factor: 5.958

2.  High prevalence of pituitary adenomas: a cross-sectional study in the province of Liege, Belgium.

Authors:  Adrian F Daly; Martine Rixhon; Christelle Adam; Anastasia Dempegioti; Maria A Tichomirowa; Albert Beckers
Journal:  J Clin Endocrinol Metab       Date:  2006-09-12       Impact factor: 5.958

3.  Pituitary pathology in Carney complex patients.

Authors:  Sotirios G Stergiopoulos; Mones S Abu-Asab; Maria Tsokos; Constantine A Stratakis
Journal:  Pituitary       Date:  2004       Impact factor: 4.107

4.  Mutations in the protein kinase A R1alpha regulatory subunit cause familial cardiac myxomas and Carney complex.

Authors:  M Casey; C J Vaughan; J He; C J Hatcher; J M Winter; S Weremowicz; K Montgomery; R Kucherlapati; C C Morton; C T Basson
Journal:  J Clin Invest       Date:  2000-09       Impact factor: 14.808

5.  Mutations of the gene encoding the protein kinase A type I-alpha regulatory subunit in patients with the Carney complex.

Authors:  L S Kirschner; J A Carney; S D Pack; S E Taymans; C Giatzakis; Y S Cho; Y S Cho-Chung; C A Stratakis
Journal:  Nat Genet       Date:  2000-09       Impact factor: 38.330

6.  Genetic heterogeneity and spectrum of mutations of the PRKAR1A gene in patients with the carney complex.

Authors:  L S Kirschner; F Sandrini; J Monbo; J P Lin; J A Carney; C A Stratakis
Journal:  Hum Mol Genet       Date:  2000-12-12       Impact factor: 6.150

7.  Pituitary disease in MEN type 1 (MEN1): data from the France-Belgium MEN1 multicenter study.

Authors:  Bruno Vergès; Françoise Boureille; Pierre Goudet; Arnaud Murat; Albert Beckers; Geneviève Sassolas; Patrick Cougard; Béatrice Chambe; Corinne Montvernay; Alain Calender
Journal:  J Clin Endocrinol Metab       Date:  2002-02       Impact factor: 5.958

8.  Germ-line mutation analysis in patients with multiple endocrine neoplasia type 1 and related disorders.

Authors:  S Giraud; C X Zhang; O Serova-Sinilnikova; V Wautot; J Salandre; N Buisson; C Waterlot; C Bauters; N Porchet; J P Aubert; P Emy; G Cadiot; B Delemer; O Chabre; P Niccoli; F Leprat; F Duron; B Emperauger; P Cougard; P Goudet; E Sarfati; J P Riou; S Guichard; M Rodier; A Meyrier; P Caron; M C Vantyghem; M Assayag; J L Peix; M Pugeat; V Rohmer; M Vallotton; G Lenoir; P Gaudray; C Proye; B Conte-Devolx; P Chanson; Y Y Shugart; D Goldgar; A Murat; A Calender
Journal:  Am J Hum Genet       Date:  1998-08       Impact factor: 11.025

9.  Pituitary magnetic resonance imaging in normal human volunteers: occult adenomas in the general population.

Authors:  W A Hall; M G Luciano; J L Doppman; N J Patronas; E H Oldfield
Journal:  Ann Intern Med       Date:  1994-05-15       Impact factor: 25.391

10.  Dominant inheritance of the complex of myxomas, spotty pigmentation, and endocrine overactivity.

Authors:  J A Carney; L S Hruska; G D Beauchamp; H Gordon
Journal:  Mayo Clin Proc       Date:  1986-03       Impact factor: 7.616

View more
  1 in total

Review 1.  Familial isolated pituitary adenomas (FIPA) and the pituitary adenoma predisposition due to mutations in the aryl hydrocarbon receptor interacting protein (AIP) gene.

Authors:  Albert Beckers; Lauri A Aaltonen; Adrian F Daly; Auli Karhu
Journal:  Endocr Rev       Date:  2013-01-31       Impact factor: 19.871

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.